Skip to main content
. 2022 Oct 24;14:17588359221122715. doi: 10.1177/17588359221122715

Table 2.

Incidence and severity of AEs (n = 1179).

MedDRA classification system preferred term All grades Severity
Grade 1 Grade 2 Grade 3 Grade 4 Grade 5
Leukopenia 944 (80.1) 99 (8.4) 380 (32.2) 372 (31.6) 93 (7.9) 0
Neutropenia 893 (75.7) 109 (9.2) 267 (22.6) 292 (24.8) 225 (19.1) 0
Anemia 797 (67.6) 144 (12.2) 443 (37.6) 171 (14.5) 39 (3.3) 0
Thrombopenia 604 (51.2) 200 (17.0) 195 (16.5) 142 (12.0) 67 (5.7) 0
Nausea 361 (30.6) 295 (25.0) 60 (5.1) 6 (0.5) 0 0
AST increased 258 (21.9) 194 (16.5) 50 (4.2) 10 (0.8) 4 (0.3) 0
ALT increased 241 (20.4) 180 (15.3) 52 (4.4) 8 (0.7) 1 (0.1) 0
Fatigue 228 (19.3) 185 (15.7) 43 (3.6) 0 0 0
Vomiting 186 (15.8) 118 (10.0) 45 (3.8) 23 (2.0) 0 0
Pain 155 (13.1) 102 (8.7) 42 (3.6) 11 (0.9) 0 0
Loss of appetite 141 (12.0) 117 (9.9) 24 (2.0) 0 0 0
Blood glucose increased 83 (7.0) 60 (5.1) 21 (1.8) 2 (0.2) 0 0
Hypocalcemia 75 (6.5) 58 (4.9) 16 (1.4) 2 (0.2) 1 (0.1) 0
Albumin decreased 76 (6.4) 72 (6.1) 4 (0.3) 0 0 0
Fever 75 (6.4) 58 (4.9) 13 (1.1) 1 (0.1) 3 (0.3) 0
Anorexia and bulimia syndrome 61 (5.2) 56 (4.7) 5 (0.4) 0 0 0
Hypoalbuminemia 61 (5.2) 50 (4.2) 11 (0.9) 0 0 0
Blood bilirubin increased 59 (5.0) 29 (2.5) 23 (2.0) 6 (0.5) 1 (0.1) 0
Hypokalemia 54 (4.6) 43 (3.6) 2 (0.2) 9 (0.8) 0 0
Cough 52 (4.4) 40 (3.4) 12 (1.0) 0 0 0
Blood uric acid increased 50 (4.2) 49 (4.2) 1 (0.1) 0 0 0
Hyponatremia 41 (3.5) 32 (2.7) 1 (0.1) 7 (0.6) 1 (0.1) 0
Hemoglobin decreased 38 (3.2) 12 (1.0) 20 (1.7) 6 (0.5) 0 0
Insomnia 37 (3.1) 32 (2.7) 5 (0.4) 0 0 0

Data were expressed as n (%).

AEs, adverse events; ALT, alanine aminotransferase; AST, aspartate aminotransferase.